5.13
price down icon0.97%   -0.05
 
loading

Finanzdaten der Imunon Inc-Aktie (IMNN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
33.23%
2.7679
4.1453 4.1462 4.9615 5.0134
Operating Income/Loss
33.23%
-2.7679
-4.1453 -4.1462 -4.9615 -5.0134
Nonoperating Income/Loss
36.21%
0.0273
0.0428 0.089 0.116 0.2253
Income/Loss From Continuing Operations Before Tax
33.20%
-2.7406
-4.1025 -5.3376 -4.8455 -4.788
Income/Loss From Continuing Operations After Tax
33.20%
-2.7406
-4.1025 -5.3376 -4.8455 -4.788
Net Income/Loss
33.20%
-2.7406
-4.1025 -4.0572 -4.8455 -4.788
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
91.23%
1.2772
14.56 1.0048 14.45 9.4009
Diluted Average Shares
91.23%
1.2772
14.56 1.0048 14.45 9.4009
Basic Earnings Per Share
667.86%
-2.15
-0.28 -0.23 -0.34 -0.51
Diluted Earnings Per Share
667.86%
-2.15
-0.28 -0.23 -0.34 -0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
Kapitalisierung:     |  Volumen (24h):